DNAJC5 and malaria: For CSP(NANP), the CHMI group showed significantly higher responses than the US naïve group (p < 1 × 10−3), with an average of five-fold higher titers; the IMRAS group also showed significantly higher responses compared to the U.S. malaria-naïve group (p < 1 × 10−4) with an average of 160-fold higher titers.